A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in Uganda.

A randomized, controlled, trial of short cycle intermittent compared to continuous antiretroviral therapy for the treatment of HIV infection in Uganda.

Short cycle treatment interruption could reduce toxicity and drug costs and contribute to further expansion of antiretroviral therapy (ART) programs.A 72 week, non-inferiority trial enrolled one hundred forty six HIV positive persons receiving ART (CD4+ cell count > or =125 cells/mm(3) and HIV RN...

Full description

Bibliographic Details
Main Authors:	Steven J Reynolds, Cissy Kityo, Claire W Hallahan, Geoffrey Kabuye, Diana Atwiine, Frank Mbamanya, Francis Ssali, Robin Dewar, Marybeth Daucher, Richard T Davey, Peter Mugyenyi, Anthony S Fauci, Thomas C Quinn, Mark R Dybul
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2010-04-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC2860845?pdf=render

Similar Items

Scaling up antiretroviral therapy: experience of the Joint Clinical Research Centre (JCRC) access programme
by: Peter Mugyenyi, et al.
Published: (2006-01-01)

Scaling up antiretroviral therapy: experience of the Joint Clinical Research Centre (JCRC) access programme
by: Peter Mugyenyi, et al.
Published: (2006-01-01)

Financial Resource Capacity Development Strategies and Public Secondary School Growth in Kira Municipality, Wakiso District, Uganda
by: Kabuye Rehmah, et al.
Published: (2022-12-01)

Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study.
by: Seth C Inzaule, et al.
Published: (2016-01-01)

Correction: Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study.
by: Seth C Inzaule, et al.
Published: (2017-01-01)

Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe.
by: Antonieta Medina Lara, et al.
Published: (2012-01-01)

Persistence of traditional and emergence of new structural drivers and factors for the HIV epidemic in rural Uganda; A qualitative study.
by: Francis Bajunirwe, et al.
Published: (2019-01-01)

HIV-associated anemia after 96 weeks on therapy: determinants across age ranges in Uganda and Zimbabwe.
by: Jaganath, D, et al.
Published: (2014)

Cost Effectiveness Analysis of Clinically Driven versus Routine Laboratory Monitoring of Antiretroviral Therapy in Uganda and Zimbabwe
by: Lara, A, et al.
Published: (2012)

Mortality in the year following antiretroviral therapy initiation in HIV-infected adults and children in Uganda and Zimbabwe.
by: Walker, A, et al.
Published: (2012)

The effect of AIDS defining conditions on immunological recovery among patients initiating antiretroviral therapy at Joint Clinical Research Centre, Uganda
by: Odere Mathew, et al.
Published: (2009-07-01)

Validation of World Health Organisation HIV/AIDS clinical staging in predicting initiation of antiretroviral therapy and clinical predictors of low CD4 cell count in Uganda.
by: Steven Baveewo, et al.
Published: (2011-01-01)

Clinical differences between younger and older adults with HIV/AIDS starting antiretroviral therapy in Uganda and Zimbabwe: a secondary analysis of the DART trial
by: Parikh, S, et al.
Published: (2013)

Social capital and resilience among people living on antiretroviral therapy in resource-poor Uganda.
by: Esther Kalule Nanfuka, et al.
Published: (2018-01-01)

Predictors of failure on second-line antiretroviral therapy with protease inhibitor mutations in Uganda
by: Hellen Musana, et al.
Published: (2021-04-01)

Long-term antiretroviral treatment adherence in HIV-infected adolescents and adults in Uganda: a qualitative study
by: Inzaule, S, et al.
Published: (2016)

Circulating plasma NT-proBNP predicts subclinical coronary atherosclerosis on CT angiography among older adults in Uganda
by: Saate S Shakil, et al.
Published: (2023-06-01)

Sex-specific performance of the ASCVD pooled cohort equation risk calculator as a correlate of coronary artery calcium in Kampala, Uganda
by: Katherine Kentoffio, et al.
Published: (2022-09-01)

The impact of first year adherence to antiretroviral therapy on long-term clinical and immunological outcomes in the DART trial in Uganda and Zimbabwe.
by: Kiwuwa-Muyingo, S, et al.
Published: (2012)

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.
by: Mugyenyi, P, et al.
Published: (2010)

Paying to Normalize Life: Monetary and Psychosocial Costs of Realizing a Normal Life in the Context of Free Antiretroviral Therapy Services in Uganda
by: Esther Kalule Nanfuka MA, et al.
Published: (2019-07-01)

Diminishing availability of publicly funded slots for antiretroviral initiation among HIV-infected ART-eligible patients in Uganda.
by: Elvin H Geng, et al.
Published: (2010-11-01)

Durable Suppression of HIV-1 after Virologic Monitoring-Based Antiretroviral Adherence Counseling in Rakai, Uganda.
by: Alexander Billioux, et al.
Published: (2015-01-01)

Gaps in vaccine management practices during vaccination outreach sessions in rural settings in southwestern Uganda
by: Atwiine Flavia, et al.
Published: (2023-11-01)

Sex, HIV Status, and Measures of Cardiac Stress and Fibrosis in Uganda
by: Jasmine Kipke, et al.
Published: (2021-06-01)

MicroRNA expression profiling in HCV-infected human hepatoma cells identifies potential anti-viral targets induced by interferon-α.
by: Xiaozhen Zhang, et al.
Published: (2013-01-01)

High level of viral suppression and low switch rate to second-line antiretroviral therapy among HIV-infected adult patients followed over five years: retrospective analysis of the DART trial.
by: Cissy Kityo, et al.
Published: (2014-01-01)

Patterns of individual and population-level adherence to antiretroviral therapy and risk factors for poor adherence in the first year of the DART trial in Uganda and Zimbabwe.
by: Muyingo, S, et al.
Published: (2008)

Institutional design and utilisation of evaluation results in Uganda’s public universities: Empirical findings from Kyambogo University
by: James Kabuye, et al.
Published: (2017-06-01)

Processes and experiences of satellite haemophilia clinic set-ups in Uganda – a short report
by: Kasirye Philip, et al.
Published: (2022-05-01)

Predictors of breastfeeding self‐efficacy among women attending an urban postnatal clinic, Uganda
by: Joyce Nankumbi, et al.
Published: (2019-07-01)

Mortality in an antiretroviral therapy programme in Jinja, south-east Uganda: a prospective cohort study
by: Coutinho Alex, et al.
Published: (2011-10-01)

Remuneration and Staff Retention in Private Secondary Schools in Mbale Municipality, Uganda
by: Wambede Issa, et al.
Published: (2020-05-01)

Distribution of HLA-B alleles in a Ugandan HIV-infected adult population: NORA pharmacogenetic substudy of DART.
by: Munderi, P, et al.
Published: (2011)

Glomerular dysfunction and associated risk factors over 4-5 years following antiretroviral therapy initiation in Africa.
by: Stöhr, W, et al.
Published: (2011)

Frequent detection of HPV before and after initiation of antiretroviral therapy among HIV/HSV-2 co-infected women in Uganda.
by: Anne F Rositch, et al.
Published: (2013-01-01)

Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda.
by: Pontiano Kaleebu, et al.
Published: (2015-01-01)

School Branding and Student Enrolment in Private Secondary Schools in Iganga Municipality, Uganda
by: Abdallah Nakalyakaani, et al.
Published: (2020-05-01)

A Sex-Stratified Analysis of Monocyte Phenotypes Associated with HIV Infection in Uganda
by: Moises A. Huaman, et al.
Published: (2021-10-01)

Assessment of second-line antiretroviral regimens for HIV therapy in Africa
by: Paton, N, et al.
Published: (2014)